(Q43112990)

14 November 2017

title

Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease (English)

1 reference

14 November 2017

4

Dominique Genest

1 reference

14 November 2017

Marc Dilauro

1

1 reference

14 November 2017

Joseph Zimpelmann

series ordinal

2

1 reference

14 November 2017

Susan J Robertson

series ordinal

3

1 reference

14 November 2017

Kevin D Burns

series ordinal

5

1 reference

14 November 2017

publication date

31 March 2010

1 reference

American Journal of Physiology - Renal Physiology

14 November 2017

published in

1 reference

14 November 2017

volume

298

1 reference

14 November 2017

issue

6

1 reference

14 November 2017

page(s)

F1523-32

1 reference

Angiotensin II type 2 receptor deficiency aggravates renal injury and reduces survival in chronic kidney disease in mice.

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Angiotensin-(1-7) and its effects in the kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Angiotensin-(1-7) and the g protein-coupled receptor MAS are key players in renal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Angiotensin-(1-7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Chronic infusion of angiotensin-(1-7) reduces heart angiotensin II levels in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Human recombinant ACE2 reduces the progression of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Characterization of susceptibility of inbred mouse strains to diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Chronic angiotensin (1-7) injection accelerates STZ-induced diabetic renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1-7) in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

Angiotensin-(1-7) activates growth-stimulatory pathways in human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

A fluorescence-based protocol for quantifying angiotensin-converting enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00426.2009

10.1152/AJPRENAL.00426.2009

21 January 2018

Identifiers

DOI

1 reference

14 November 2017

1 reference